HW
WST icon

Hancock Whitney’s West Pharmaceutical WST Stock Holding History

Hancock Whitney’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-691
Closed -$226K – 669
2024
Q4 		$226K Sell
691
-912
-57% -$287K 0.01% 589
2024
Q3 		$481K Sell
1,603
-23,805
-94% -$7.29M 0.02% 446
2024
Q2 		$8.37M Buy
25,408
+451
+2% +$159K 0.28% 78
2024
Q1 		$9.88M Buy
24,957
+1,482
+6% +$548K 0.34% 69
2023
Q4 		$8.27M Buy
+23,475
New +$8.31M 0.31% 78
2022
Q2 		– Sell
-539
Closed -$221K – 682
2022
Q1 		$221K Buy
539
+17
+3% +$6.66K 0.01% 648
2021
Q4 		$245K Buy
522
+24
+5% +$10.3K 0.01% 631
2021
Q3 		$211K Buy
+498
New +$210K 0.01% 644

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return